Psychometric validation of the Polish version of the Central Sensitization Inventory in subjects with chronic spinal pain.


Journal

BMC neurology
ISSN: 1471-2377
Titre abrégé: BMC Neurol
Pays: England
ID NLM: 100968555

Informations de publication

Date de publication:
11 Dec 2021
Historique:
received: 13 06 2021
accepted: 30 11 2021
entrez: 11 12 2021
pubmed: 12 12 2021
medline: 15 12 2021
Statut: epublish

Résumé

Central sensitization is an amplification of neuronal signaling within the central nervous system. The Central Sensitization Inventory was introduced in 2012. A Polish version of the CSI (CSI-Pol) was developed in 2019, but it was not psychometrically validated. The aim of this study was to validate the CSI-Pol in a sample of Polish-speaking patients with chronic spinal pain and compare them with a group of healthy control subjects. The CSI-Pol was administered to 151 patients with chronic spinal pain recruited from two centers. It was re-administered 7 days later. The psychometric properties were then evaluated, including test-retest reliability, construct validity, factor structure and internal consistency. We correlated the CSI-Pol with functional scales, depression and social support scales and compared CSI-Pol scores in the clinical subjects with 30 healthy control subjects recruited from medical staff and their families. The CSI-Pol demonstrated excellent internal consistency (Cronbach's α =0,933) and test-retest reliability (Intraclass Correlation Coefficients - ICC =0.96), as well as significant positive associations with other patient-reported scales, including the Neck Disability Index (r = 0.593), Revised Oswestry Low Back Pain Disability Questionnaire (r = 0.422), and other measures of functional and depressive states. An exploratory factor analysis resulted in a 4-factor model. CSI-Pol scores in the clinical sample (35.27 ± 17.25) were significantly higher than the control sample (23.3 ± 8.9). The results of this study suggest that the CSI-Pol may be a useful clinical tool for assessing central sensitization related symptoms and guiding appropriate treatment in Polish-speaking patients with spinal pain.

Sections du résumé

BACKGROUND BACKGROUND
Central sensitization is an amplification of neuronal signaling within the central nervous system. The Central Sensitization Inventory was introduced in 2012. A Polish version of the CSI (CSI-Pol) was developed in 2019, but it was not psychometrically validated. The aim of this study was to validate the CSI-Pol in a sample of Polish-speaking patients with chronic spinal pain and compare them with a group of healthy control subjects.
METHODS METHODS
The CSI-Pol was administered to 151 patients with chronic spinal pain recruited from two centers. It was re-administered 7 days later. The psychometric properties were then evaluated, including test-retest reliability, construct validity, factor structure and internal consistency. We correlated the CSI-Pol with functional scales, depression and social support scales and compared CSI-Pol scores in the clinical subjects with 30 healthy control subjects recruited from medical staff and their families.
RESULTS RESULTS
The CSI-Pol demonstrated excellent internal consistency (Cronbach's α =0,933) and test-retest reliability (Intraclass Correlation Coefficients - ICC =0.96), as well as significant positive associations with other patient-reported scales, including the Neck Disability Index (r = 0.593), Revised Oswestry Low Back Pain Disability Questionnaire (r = 0.422), and other measures of functional and depressive states. An exploratory factor analysis resulted in a 4-factor model. CSI-Pol scores in the clinical sample (35.27 ± 17.25) were significantly higher than the control sample (23.3 ± 8.9).
CONCLUSION CONCLUSIONS
The results of this study suggest that the CSI-Pol may be a useful clinical tool for assessing central sensitization related symptoms and guiding appropriate treatment in Polish-speaking patients with spinal pain.

Identifiants

pubmed: 34893020
doi: 10.1186/s12883-021-02510-3
pii: 10.1186/s12883-021-02510-3
pmc: PMC8665486
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

483

Informations de copyright

© 2021. The Author(s).

Références

Pain Physician. 2015 May-Jun;18(3):E333-46
pubmed: 26000680
Lancet. 2017 Feb 18;389(10070):736-747
pubmed: 27745712
Pain. 2019 Apr;160(4):833-843
pubmed: 30531308
Ann Rheum Dis. 2005 Jun;64(6):921-5
pubmed: 15897311
Pain Pract. 2018 Apr;18(4):463-472
pubmed: 28777895
Disabil Rehabil. 2013;35(25):2132-7
pubmed: 23627530
Man Ther. 2010 Apr;15(2):135-41
pubmed: 20036180
J Manipulative Physiol Ther. 1991 Sep;14(7):409-15
pubmed: 1834753
Open Orthop J. 2013 Sep 20;7:494-505
pubmed: 24115971
Reumatologia. 2019;57(3):129-134
pubmed: 31462827
Pain. 2001 Sep;93(3):317-325
pubmed: 11514090
Rheumatol Int. 2013 May;33(5):1277-81
pubmed: 23124732
Pain. 2016 Nov;157(11):2420-2423
pubmed: 27200490
Clin J Pain. 2016 Jul;32(7):624-30
pubmed: 26418360
Springerplus. 2016 Oct 21;5(1):1837
pubmed: 27818875
J Psychosom Res. 2019 Feb;117:32-40
pubmed: 30665594
Phys Ther. 2017 Mar 1;97(3):338-353
pubmed: 28403431
Ann Rheum Dis. 2014 Jun;73(6):968-74
pubmed: 24665116
Pain Pract. 2012 Apr;12(4):276-85
pubmed: 21951710
Eur J Clin Invest. 2012 Feb;42(2):203-12
pubmed: 21793823
Pain Suppl. 1986;3:S1-226
pubmed: 3461421
J Neurosci. 2008 May 14;28(20):5189-94
pubmed: 18480275
PLoS One. 2017 Dec 7;12(12):e0188719
pubmed: 29216211
J Pain. 2018 Mar;19(3):317-329
pubmed: 29198933
Am J Psychiatry. 1991 Dec;148(12):1721-6
pubmed: 1957937
Pain Pract. 2017 Feb;17(2):166-175
pubmed: 26989894
Musculoskelet Sci Pract. 2018 Oct;37:20-28
pubmed: 29966856
J Psychosom Res. 1987;31(2):251-9
pubmed: 3585827
Physiotherapy. 1980 Aug;66(8):271-3
pubmed: 6450426
Eur Spine J. 2006 Mar;15 Suppl 2:S192-300
pubmed: 16550448
Pain Pract. 2020 Feb;20(2):188-196
pubmed: 31605651
J Pain. 2008 Apr;9(4):373-9
pubmed: 18203665
Arch Intern Med. 2003 Nov 10;163(20):2433-45
pubmed: 14609780
Spine (Phila Pa 1976). 2011 Dec 15;36(26):E1722-9
pubmed: 21394073
BMC Musculoskelet Disord. 2021 Aug 18;22(1):708
pubmed: 34407773
Pain. 2011 Mar;152(3 Suppl):S2-S15
pubmed: 20961685
BMC Neurol. 2020 Jul 27;20(1):286
pubmed: 32718330
Neuroscientist. 2019 Dec;25(6):583-596
pubmed: 30387689
Neurogastroenterol Motil. 2010 Aug;22(8):893-900
pubmed: 20465594
Clin J Pain. 2015 Apr;31(4):323-32
pubmed: 24806467
J Pain. 2013 May;14(5):438-45
pubmed: 23490634
J Pain Res. 2017 Sep 01;10:2109-2122
pubmed: 28979158

Auteurs

Barbara Kosińska (B)

Department of Neurology and Stroke, District Hospital, Chrzanów, Poland.

Beata Tarnacka (B)

Department of Rehabilitation, Medical University of Warsaw, Warsaw, Poland. btarnacka@wum.edu.pl.

Paweł Turczyn (P)

Department of Rehabilitation, Medical University of Warsaw, Warsaw, Poland.

Grażyna Gromadzka (G)

Collegium Medicum, Faculty of Medicine, Cardinal Stefan Wyszynski University, Warsaw, Poland.

Małgorzata Malec-Milewska (M)

Department of Anesthesiology and Intensive Care, Medical Center for Postgraduate Education, Warsaw, Poland.

Dorota Janikowska-Hołowenko (D)

Pomorskie Centrum Reumatologiczne im. dr Jadwigi Titz - Kosko, Sopot, Poland.

Randy Neblett (R)

PRIDE Research Foundation, Dallas, TX, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH